ACG Wealth
TEVA icon

ACG Wealth’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

ACG Wealth’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-260
Closed -$2K – 926
2022
Q2 		$2K Buy
+260
New +$2.26K ﹤0.01% 835

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

ACG Wealth's TEVA Position: Q3 2022 in Review

ACG Wealth sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2022, closing a stake of 260 shares — an estimated $2K sold.

ACG Wealth first reported a position in TEVA in Q2 2022 and held it in 1 quarter. The position peaked at $2K in Q2 2022. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • ACG Wealth reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2022 after selling out during the quarter.
  • ACG Wealth sold 260 Teva Pharmaceutical Industries Limited shares in Q3 2022, an estimated $2K.
  • ACG Wealth first reported a position in Teva Pharmaceutical Industries Limited in Q2 2022 and held it in 1 quarter.
  • ACG Wealth's Teva Pharmaceutical Industries Limited position peaked at $2K in Q2 2022.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.